These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22926481)

  • 1. Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs.
    Gómez-Moreno G; Guardia J; Aguilar-Salvatierra A; Cabrera-Ayala M; Maté-Sánchez de-Val JE; Calvo-Guirado JL
    Med Oral Patol Oral Cir Bucal; 2013 Jan; 18(1):e49-55. PubMed ID: 22926481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: a double-blind, randomized clinical trial.
    Gómez-Moreno G; Aguilar-Salvatierra A; Guardia J; Uribe-Marioni A; Cabrera-Ayala M; Delgado-Ruiz RA; Calvo-Guirado JL
    Depress Anxiety; 2013 Feb; 30(2):137-42. PubMed ID: 23124914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of a topical sialogogue spray containing malic acid 1% in elderly people with xerostomia: a double-blind, randomized clinical trial.
    Gómez-Moreno G; Cabrera-Ayala M; Aguilar-Salvatierra A; Guardia J; Ramírez-Fernández MP; González-Jaranay M; Calvo-Guirado JL
    Gerodontology; 2014 Dec; 31(4):274-80. PubMed ID: 23294350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease.
    Bardellini E; Amadori F; Conti G; Veneri F; Majorana A
    Med Oral Patol Oral Cir Bucal; 2019 Mar; 24(2):e190-e194. PubMed ID: 30818311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a 1% malic acid spray for xerostomia treatment: A systematic review and meta-analysis.
    Liu G; Qiu X; Tan X; Miao R; Tian W; Jing W
    Oral Dis; 2023 Apr; 29(3):862-872. PubMed ID: 34954846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 1% malic acid spray on the oral health-related quality of life of patients with xerostomia.
    Niklander S; Fuentes F; Sanchez D; Araya V; Chiappini G; Martinez R; Marshall M
    J Oral Sci; 2018; 60(2):278-284. PubMed ID: 29925712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1% malic acid spray on diabetes mellitus-induced xerostomia: A randomized clinical trial.
    Muhamed SA; Moussa EM; Aboasy NK; Gaweesh YY
    Oral Dis; 2024 Mar; 30(2):631-638. PubMed ID: 35913424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy of a Dietary Supplement with Carnosine and Hibiscus Sabdariffa L. (AqualiefTM) in Patients with Xerostomia: a Randomized, Placebo-Controlled, Double-Blind Trial.
    Levrini L; Azzi L; Bossi S
    Clin Ter; 2020; 171(4):e295-e301. PubMed ID: 32614361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products for the management of xerostomia: a randomized, double-blinded, placebo-controlled clinical trial.
    Navarro Morante A; Wolff A; Bautista Mendoza GR; López-Jornet P
    J Oral Pathol Med; 2017 Feb; 46(2):154-160. PubMed ID: 27550537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of photobiomodulation in salivary production of patients with xerostomy induced by anti-hypertensive drugs: Study protocol clinical trial (SPIRIT compliant).
    Varellis MLZ; Gonçalves MLL; Pavesi VCS; Horliana ACRT; de Fátima Teixeira da Silva D; Motta LJ; Barbosa Filho VF; Bezerra CDS; Silva FGD; Bussadori SK; Deana AM
    Medicine (Baltimore); 2020 Apr; 99(16):e19583. PubMed ID: 32311925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications.
    Nonzee V; Manopatanakul S; Khovidhunkit SO
    J Med Assoc Thai; 2012 Jan; 95(1):96-104. PubMed ID: 22379748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for the treatment of xerostomia: A randomized controlled clinical trial.
    Marín C; Díaz-de-Valdés L; Conejeros C; Martínez R; Niklander S
    J Clin Exp Dent; 2021 Feb; 13(2):e104-e111. PubMed ID: 33574994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-related outcomes in Sjögren syndrome treated with stimulants of salivary secretion: Randomized clinical trial.
    da Mata ADSP; Amaral JPAR; Thomson WM; Barcelos F; Vaz Patto J; Pereira RMN; Marques DNDS
    Oral Dis; 2020 Mar; 26(2):313-324. PubMed ID: 31814226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of saliva substitutes and stimulants in the treatment of dry mouth.
    See L; Mohammadi M; Han PP; Mulligan R; Enciso R
    Spec Care Dentist; 2019 May; 39(3):287-297. PubMed ID: 30811076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia and Aalivary Flow in Patients Taking Antihypertensive Drugs.
    Ramírez Martínez-Acitores L; Hernández Ruiz de Azcárate F; Casañas E; Serrano J; Hernández G; López-Pintor RM
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32260482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of salivary substitutes versus a natural sialogogue (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study.
    Femiano F; Rullo R; di Spirito F; Lanza A; Festa VM; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):e15-20. PubMed ID: 21507689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
    Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
    Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ.
    Bardow A; Nyvad B; Nauntofte B
    Arch Oral Biol; 2001 May; 46(5):413-23. PubMed ID: 11286806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.
    Sánchez-Blanco I; Rodríguez-Téllez M; Corcuera-Flores JR; González-Blanco C; Torres-Lagares D; Serrera-Figallo MÁ; Machuca-Portillo G
    Med Oral Patol Oral Cir Bucal; 2020 Nov; 25(6):e818-e826. PubMed ID: 33037808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.